We are live on ! Find out more
LMAT icon

LeMaitre Vascular

291 hedge funds and large institutions have $1.95B invested in LeMaitre Vascular in 2024 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 106 increasing their positions, 94 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

194% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 16

80% more call options, than puts

Call options by funds: $483K | Put options by funds: $269K

15% more capital invested

Capital invested by funds: $1.69B → $1.95B (+$261M)

13% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 94

11% more funds holding

Funds holding: 261291 (+30)

2% more ownership

Funds ownership: 91.45%93.45% (+2%)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
291
Holders Change
+30
Holders Change %
+11.49%
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
47
Increased
106
Reduced
94
Closed
16
Calls
$483K
Puts
$269K
Net Calls
+$214K
Net Calls Change
-$8K
Name Holding Trade Value Shares
Change
Change in
Stake
CIC
176
Cornercap Investment Counsel
Georgia
$414K -$359K -4,143 -48%
COPPSERS
177
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$406K +$5.63K +65 +2%
Acadian Asset Management
178
Acadian Asset Management
Massachusetts
$396K +$261K +3,007 +236%
SOW
179
State of Wyoming
Wyoming
$393K +$68.9K +795 +23%
IIM
180
INTECH Investment Management
Florida
$377K +$352K +4,060 New
AG
181
Algert Global
California
$375K -$2.72M -31,384 -89%
CG
182
Cynosure Group
Utah
$365K -$61.6K -711 -15%
XT
183
XTX Topco
Cayman Islands
$344K +$321K +3,705 New
Creative Planning
184
Creative Planning
Kansas
$334K +$53.5K +617 +21%
AFG
185
Albion Financial Group
Utah
$334K -$7.11K -82 -2%
PCM
186
Prelude Capital Management
New York
$323K -$23.6K -272 -7%
HF
187
HRT Financial
New York
$317K +$296K +3,420 New
LA
188
Lindenwold Advisors
Pennsylvania
$312K +$1.3K +15 +0.4%
WIC
189
Whitegate Investment Counselors
New Hampshire
$304K +$520 +6 +0.2%
NRD
190
Nebula Research & Development
New York
$303K -$57.2K -660 -17%
Envestnet Portfolio Solutions
191
Envestnet Portfolio Solutions
Illinois
$290K -$520 -6 -0.2%
Robeco Institutional Asset Management
192
Robeco Institutional Asset Management
Netherlands
$283K +$264K +3,047 New
Mercer Global Advisors
193
Mercer Global Advisors
Colorado
$282K +$173 +2 +0.1%
QC
194
Quadrature Capital
United Kingdom
$281K +$262K +3,020 New
FLI
195
Family Legacy Inc
South Carolina
$279K
Arrowstreet Capital
196
Arrowstreet Capital
Massachusetts
$269K +$251K +2,896 New
A
197
AlphaQuest
New York
$265K +$247K +2,855 New
OQS
198
Occudo Quantitative Strategies
Florida
$264K -$253K -2,916 -51%
FLPIM
199
F.L. Putnam Investment Management
Massachusetts
$262K +$10.1K +117 +4%
ONB
200
Old National Bancorp
Indiana
$262K +$4.25K +49 +2%

LMAT Hedge Fund Activity: Q3 2024 in Review

291 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2024, worth a combined $1.95B — up 15% from $1.69B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new LMAT positions and 16 closed out — a net gain of 31 holders — while 106 added to existing stakes and 94 trimmed.

The largest buyer was BlackRock, adding an estimated $17.3M. The largest seller was Cramer Rosenthal McGlynn, exiting entirely with an estimated $20.5M sold.

  • 291 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2024, up from 261 in Q2 2024.
  • Funds reported $1.95B of LeMaitre Vascular stock for Q3 2024, up 15% quarter-over-quarter.
  • 47 funds opened new LeMaitre Vascular positions in Q3 2024 and 16 closed out, a net change of +31 holders.
  • The largest LeMaitre Vascular buyer in Q3 2024 was BlackRock, an estimated $17.3M added.
  • The largest LeMaitre Vascular seller in Q3 2024 was Cramer Rosenthal McGlynn, an estimated $20.5M sold.

Based on aggregated 13F filings for Q3 2024.